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INTRODUCTION 
The legalization of medical cannabis has sparked intense debate 
throughout the United States in recent years. While states such as Colorado 
and Alaska have boldly legalized cannabis for recreational use,1 other states 
have passed legislation that legalizes cannabis or some of its derivatives for 
specified medical uses.2 Against the backdrop of federal illegality of cannabis 
in all of its forms, states that have legalized medical cannabis have adopted 
different regulatory systems that seem to have a common nucleus. 
As of June 2017, twenty-nine states, the District of Columbia, Guam, 
and Puerto Rico have legalized cannabis for medical use.3 An additional 
sixteen states have legalized cannabidiol (CBD) oil for certain medical 
conditions.4 CBD, unlike tetrahydrocannabinol (THC), is a non-psychoactive 
part of the cannabis plant and is commonly used in an oil form.5 Thus, while 
using cannabis that contains THC may have psychoactive as well as medical 
effects on its users, users of CBD oil can still reap many of the medical 
benefits of cannabis without experiencing the psychoactive effects resulting 
from the THC.6 This key distinction may be the biggest reason many states 
that have traditionally opposed legalizing cannabis for medical purposes 
have legalized the use of CBD oil for limited medical purposes (commonly 
for the treatment of epilepsy).7 
In 2013, the Department of Justice released a memo stating it had 
made a policy decision to not prosecute individuals lawfully using medical 
cannabis under state law so long as those state systems conform to eight 
                                                 
 1. COLO. CONST. art. XVIII, § 16(5)(a); ALASKA STAT. § 11.71.190 (1999). 
 2. See State Medical Marijuana Laws, NATIONAL CONFERENCE OF STATE 
LEGISLATORS, http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx (last 
visited Jan. 27, 2017). 
 3. See id. 
 4. See 16 States With Laws Specifically About Legal Cannabidiol (CBD), PROCON, 
http://medicalmarijuana.procon.org/view.resource.php?resourceID=006473 (last visited Jan. 
27, 2017). 
 5. See John Ingold, Non-Psychoactive CBD Oil Made From Marijuana Plants Poised 
To Be Game-Changer (Oct. 2, 2016), http://www.denverpost.com/2014/03/29/non-
psychoactive-cbd-oil-made-from-marijuana-plants-poised-to-be-game-changer/. 
 6. Id. 
 7. See PROCON, supra note 4. 
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general criteria (e.g., ensuring doctors do not participate in drug trafficking, 
ensuring children do not have easy access to cannabis, etc.).8 This 
announcement has led to persisting state experimentation in the area of 
regulating cannabis for medical use. 
States that have legalized some form of medical cannabis (“legalized 
states”) have different systems of distribution. Nevertheless, most legalized 
states have a reasonably similar system of regulation.9 Generally, patients 
seeking to treat their health conditions with medical cannabis must go to a 
health care professional with recommendation privileges (governed by state 
statute) and get a recommendation from that professional to use medical 
cannabis. Patients will only be able to get such a recommendation if they 
have a “qualifying medical condition” listed by state statute. Once a patient 
with a qualifying medical condition gets a recommendation from a privileged 
health care professional, the patient usually must register with the state’s 
Department of Health. All legalized states issue ID cards to patients upon 
verification of a privileged physician’s recommendation, proof of in-state 
residency, and payment of an application fee, and put the patient in a 
confidential state registry containing all cardholders. For states that allow 
qualifying minor children to use medical cannabis in some form, that minor 
child must designate a “caregiver” (generally the child’s parent or legal 
guardian), and the caregiver is the one to whom the ID card is assigned and 
has the privilege of purchasing, possessing, and in some cases, cultivating 
the medical cannabis. Adults may also appoint caregivers to assist them in 
their treatment plans. Once a patient or her caregiver has an ID card, she may 
go to an approved dispensary and purchase medical cannabis, subject to 
certain possession limits and the presentation of her ID card. Generally, 
dispensaries also must register with the state’s Department of Health, and 
additional fees and licensure requirements apply to individuals seeking to 
start a dispensary.10 Some states allow patients to personally cultivate 
medical cannabis for their own use, again subject to certain restrictions.11 
Patients generally must carry their ID cards with them while they are 
traveling with medical cannabis in their possession. Finally, patients must 
periodically renew their ID cards with a new recommendation from a 
privileged health care professional and the payment of a renewal fee.12 
A number of factors comprise the variations found in each 
distribution system. This Note examines a variety of factors common to 
existing state regulatory systems to identify the best ways to regulate the 
distribution of medical cannabis. These factors include: (1) the number and 
type of qualifying medical conditions, (2) patient access to medical cannabis 
                                                 
 8. Guidance Regarding Marijuana Enforcement, Op. Att’y Gen. 1, 1-4 (2013). 
 9. See Medical Marijuana, THE NATIONAL ORGANIZATION FOR THE REFORM OF 
MARIJUANA LAWS, http://norml.org/legal/medical-marijuana-2 (last visited Jan. 27, 2017). 
 10. Id. 
 11. Id. 
 12. Id. 
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through personal cultivation and dispensaries, (3) privileged health care 
professionals and recommendations of medical cannabis to patients, and (4) 
patient registration requirements and state reciprocity. In analyzing each 
factor, this Note discusses existing state systems that excel in relation to each 
factor and existing state systems that perform poorly in relation to each 
factor. Finally, this Note argues that the best regulatory scheme for the 
distribution of medical cannabis is ultimately a mixture of several aspects of 
existing systems and some aspects that no system has yet adopted. This Note 
will also argue that this ideal regulatory system should be adopted by all 
states to increase patient access and choice, decrease costs, improve 
efficiency, and maximize the individual liberty for patients, while 
simultaneously protecting the public. 
The best regulatory system for the distribution of medical cannabis 
should embody an expansive list of qualifying medical conditions with the 
ability to be easily expanded as new medical and scientific discoveries 
pertaining to the use of medical cannabis emerge. Second, the ideal 
regulatory system should allow for personal cultivation and easy 
establishment of dispensaries, so to improve patient access to medical 
cannabis and achieve lower prices through market competition. Third, to 
ensure patients have enough ascertainable health care professionals to serve 
their needs, the model regulatory system should grant recommendation 
privileges to a broad array of health care professionals that are easily 
identified within the state through a published list of all professionals with 
recommendation privileges. Finally, the ideal regulatory system should 
include an efficient, cheap, and compassionate registration system through 
low application fees and reciprocity provisions. 
I.  MODEL ACT FOR STATE SYSTEMS OF DISTRIBUTION 
(1) Purpose and Findings.13 
(a) The recorded use of cannabis as medicine goes back nearly 5,000 
years. Modern medical research has confirmed the beneficial uses of 
cannabis in treating or alleviating the pain, nausea, and other symptoms 
associated with a variety of debilitating medical conditions, including cancer, 
multiple sclerosis, and HIV/AIDS, as found by the National Academy of 
Sciences’ Institute of Medicine in March 1999. 
(b) Studies published since the 1999 Institute of Medicine report 
continue to show the therapeutic value of cannabis in treating a wide array of 
debilitating medical conditions. These include relief of the neuropathic pain 
caused by multiple sclerosis, HIV/AIDS, and other illnesses that often fail to 
respond to conventional treatments and relief of nausea, vomiting, and other 
                                                 
 13. This model section uses the statutory language found in § 5 of the Compassionate 
Use of Medical Cannabis Pilot Program Act, the statute legalizing cannabis for medical 
purposes in Illinois. 410 ILL. COMP. STAT. 130/5 (2016). 
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side effects of drugs used to treat HIV/AIDS and hepatitis C, increasing the 
chances of patients continuing on life-saving treatment regimens. 
(c) Cannabis has many currently accepted medical uses in the United 
States, having been recommended by thousands of licensed physicians to at 
least 600,000 patients in states with medical cannabis laws. The medical 
utility of cannabis is recognized by a wide range of medical and public health 
organizations, including the American Academy of HIV Medicine, the 
American College of Physicians, the American Nurses Association, the 
American Public Health Association, the Leukemia & Lymphoma Society, 
and many others. 
(d) Data from the Federal Bureau of Investigation’s Uniform Crime 
Reports and the Compendium of Federal Justice Statistics show that 
approximately 99 out of every 100 cannabis arrests in the U.S. are made 
under state law, rather than under federal law. Consequently, changing state 
law will have the practical effect of protecting from arrest the vast majority 
of seriously ill patients who have a medical need to use cannabis. 
(2) Definitions. 
(a) “Qualifying medical condition” means one or more of the 
following: 
(A) cancer, glaucoma, positive status for human 
immunodeficiency virus, acquired immune deficiency syndrome, 
hepatitis C, amyotrophic lateral sclerosis, Crohn’s disease, agitation 
of Alzheimer’s disease, cachexia/wasting syndrome, muscular 
dystrophy, severe fibromyalgia, spinal cord disease, including but 
not limited to arachnoiditis, Tarlov cysts, hydromyelia, 
syringomyelia, Rheumatoid arthritis, fibrous dysplasia, spinal cord 
injury, traumatic brain injury and post-concussion syndrome, 
Multiple Sclerosis, Arnold-Chiari malformation and Syringomyelia, 
Spinocerebellar Ataxia (SCA), Parkinson’s, Tourette’s, Myoclonus, 
Dystonia, Reflex Sympathetic Dystrophy, RSD (Complex Regional 
Pain Syndromes Type I), Causalgia, CRPS (Complex Regional Pain 
Syndromes Type II), Neurofibromatosis, Chronic Inflammatory 
Demyelinating Polyneuropathy, Sjogren’s syndrome, Lupus, 
Interstitial Cystitis, Myasthenia Gravis, Hydrocephalus, nail-patella 
syndrome, residual limb pain, seizures (including those 
characteristic of epilepsy), post-traumatic stress disorder (PTSD), or 
the treatment of these conditions;14 or 
 
                                                 
 14. This is the list of “debilitating medical conditions” found in § 10(h) of Illinois’ 
Compassionate Use of Medical Cannabis Pilot Program Act. 410 ILL. COMP. STAT. 130/10. 
This is perhaps the largest statutory list of qualifying medical conditions currently available 
in any legalized state. 
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(B) Any other chronic or persistent medical symptom that 
either:15 
(i) Substantially limits the ability of the person to 
conduct one or more major life activities as defined in the 
Americans with Disabilities Act of 1990; or 
(ii) If not alleviated, may cause serious harm to the 
patient’s safety or physical or mental health. 
(b) “Department of Health” means the governmental department and 
any of its relevant agencies authorized to promulgate rules and regulations 
pertinent to this Model Act. 
(c) “Qualified individual” means an individual duly licensed and 
authorized under the requirements of this Model Act to possess and purchase 
medical cannabis in this state. 
(d) “Registered dispensary” means a corporation, partnership, 
limited liability company, or other legally authorized entity that acts as a 
dispensary that meets the requirements of § 4 of this Model Act and 
distributes medical cannabis in one or more of its forms. 
(e) “Practitioner” means any physician licensed to practice medicine 
in any state in the United States or any registered and licensed nurse 
practitioner or any registered and licensed physician assistant in any state in 
the United States.16 
(f) “Recommendation privileges” means the right of a Practitioner to 
provide a patient with a recommendation for medical cannabis within this 
state. 
(g) “Recommendation” means a recommendation to use medical 
cannabis to a patient by a Practitioner for the treatment of the individual’s 
qualifying medical condition. 
(h) “Registered Identification Card” means an identification card 
issued by the Department of Health to a Qualified Individual or the Qualified 
Individual’s caregiver. 
(3) Personal cultivation.17 
(a) To cultivate cannabis in this state, a qualified individual must: 
(A) Be twenty-one (21) years of age or older; and 
                                                 
 15. This subsection is based on the statutory language found in CAL. HEALTH & 
SAFETY CODE § 11362.7(12)(A)-(B) (West 2004), a part of California’s statutory scheme 
defining “serious medical conditions.” 
 16. This definition is intended to extend recommendation privileges within the state to 
nurse practitioners, physician assistants, or physicians that are licensed in any other state in 
the United States. 
 17. This section’s language has been taken from OR. ADMIN. R. 333-008-0025 (2005) 
and OR. ADMIN. R. 333-008-1030 (2005), part of Oregon’s regulatory scheme legalizing 
medical cannabis, and modified to fit the purposes of the Model Act. 
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(B) Not have been convicted of a Class A or Class B felony 
under this state’s criminal code for the manufacture or delivery of a 
controlled substance in Schedule I or Schedule II: 
(i) Within the previous two years; or 
(ii) More than once. 
(b) In addition to the application review required by this state’s law, 
the Department of Health must: 
(A) Conduct a criminal background check on any individual; 
(B) Verify the individual’s age; 
(C) Verify the zoning of the grow site address if the grow 
site is within city limits; and 
(D) Determine the number of plants that are permitted at the 
grow site address. 
(c) Unless the Department of Health has received a request for a 
grandfathered grow site address under state law, the grow site plant limits, 
on and after March 1, 201718, are as follows: 
(A) A maximum of twelve (12) mature marijuana plants if 
the grow site location is within city limits and zoned residential; or 
(B) A maximum of forty-eight (48) mature marijuana plants 
if the grow site location is within city limits but not zoned residential 
or outside city limits. 
(4) Incorporation of Dispensaries.19 
(a) To register a medical marijuana dispensary a person must: 
(A) Submit an initial application on a form prescribed by the 
Department of Health that includes but is not limited to: 
(i) The name of the individual who owns the 
dispensary or, if a business entity owns the dispensary, the 
name of each individual who has a financial interest in the 
dispensary; 
(ii) The name of the individual or individuals 
responsible for the dispensary, if different from the name of 
the individual who owns the dispensary, with one of the 
individuals responsible for the dispensary identified as the 
primary person responsible for the dispensary; 
(iii) The physical and mailing address of the medical 
marijuana dispensary; and 
(B) Application and registration fee. 
                                                 
 18. This date could be changed by any state legislature adopting this Model Act to 
reflect the date at which it wishes the new grow site plant limits to take effect. 
 19. This section is based on OR. ADMIN. R. 333-008-1020 (2005) and addresses the 
requirements for the licensing of a dispensary as well as some areas where dispensaries are 
not allowed. 
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(b) An initial application for the registration of a dispensary must be 
submitted electronically via the Department of Health’s website, [insert URL 
to the State Department of Health’s website here]20. 
(c) If an initial application is submitted along with the required fees, 
the Department of Health will notify the applicant in writing that the 
application has been received. Within thirty (30) calendar days of the mailing 
of the written notice of acceptance, the following information must be 
received by the Department of Health: 
(A) For each individual named in the application: 
(i) A legible copy of the individual’s valid 
government issued photographic identification that includes 
last name, first name, and date of birth; 
(ii) Information, fingerprints, and fees required for a 
criminal background check in accordance with this state’s 
law; and 
(iii) An individual history form and any information 
identified in the form that is required to be submitted in 
accordance with the rules promulgated by the Department of 
Health; 
(B) A written statement from an authorized official of the 
local government that the proposed location of the dispensary is not 
located in an area that is zoned for residential use as that term is 
defined in under this state’s law; 
(C) Proof that the business is registered or has filed an 
application to register as a business with this state’s Office of the 
Secretary of State, including proof of registration for any doing 
business as (DBA) registration; 
(D) Documentation, in a format prescribed by the Authority, 
that the proposed location of the dispensary is not within 1,000 feet 
of: 
(i) The real property comprising a public or private 
elementary or secondary school, except as otherwise 
provided by the laws of this state; or 
(ii) A registered dispensary. 
(E) A scaled site plan of the parcel on which the premises 
proposed for registration is located, including: 
(i) Cardinal directional references; 
(ii) Bordering streets and the names of the streets; 
(iii) Identification of the building or buildings in 
which the proposed dispensary is to be located; 
(iv) The dimensions of the proposed premises of the 
dispensary; 
                                                 
 20. The URL for the state’s Department of Health should be inserted here. 
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(v) Identification of other buildings or property 
owned by or under the control of the applicant on the same 
parcel or tax lot as the premises proposed for registration that 
will be used in the business; and 
(vi)  Identification of any residences on the parcel or 
tax lot. 
(F) A scaled floor plan of all enclosed areas of the premises 
at the proposed location that will be used in the business with clear 
identification of walls, partitions, counters, windows, all areas of 
ingress and egress, intended uses of all spaces and all limited access 
areas; and 
(G) Documentation that shows the applicant has lawful 
possession of the proposed location of the dispensary. 
(d) The Department of Health shall have the authority to promulgate 
all rules and regulations pertaining to the fee schedule for applications under 
this section, provided that the fee for an application under this section shall 
not exceed $4,000. 
(5) Practitioner Recommendation Privileges. 
(a) Any Practitioner has the privilege to recommend medical 
cannabis to a patient who is domiciled in this State and has a qualifying 
medical condition within the meaning of this Model Act.21 
(b) The Department of Health shall, on its Internet website, publish 
and maintain a current list of all Practitioners within this state that have 
recommendation privileges under this Model Act.22 
(6) Registered Identification Cards and Reciprocity. 
(a) An individual shall not be exempt from criminal penalties for 
possession or cultivation of marijuana in this state unless such individual 
registers with the Department of Health after receiving a Recommendation 
from a Practitioner and receives a Registered Identification Card from the 
Department of Health.23 
(b) Upon presentation of a valid in-state photo ID, a $25 registration 
fee, and a Practitioner’s Recommendation, the Department of Health shall 
issue the presenting individual (or, if the Recommendation is for a minor, to 
the caregiver) a Registered Identification Card. A Registered Identification 
Card expires two (2) years after it is issued. 
                                                 
 21. This provision is intended to automatically grant recommendation privileges to 
physicians, registered nurse assistants, and physician assistants duly licensed and registered 
in any state in the United States. 
 22. This section is intended to ensure that a state’s Department of Health will publish a 
current list of all practitioners within the state who have recommendation privileges. 
 23. This provision is intended to only give criminal protection to Qualified Individuals 
within the meaning of the Model Act. 
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(c) A Qualified Individual or a Qualified Individual’s caregiver may 
renew an expired Registered Identification Card by presenting a valid in-state 
photo ID, a $25 renewal fee, and a Practitioner’s Recommendation to the 
Department of Health. 
(d) Notwithstanding the other provisions of this Model Act, if a 
Practitioner determines that an individual’s qualifying medical condition is 
incurable and permanent, a Registered Identification Card issued to such 
individual shall not expire. 
(e) The Department of Health shall not issue a Registered 
Identification Card to an individual under the age of eighteen (18). If an 
individual under the age of eighteen (18) presents two (2) Recommendations 
from two (2) different Practitioners and designates a parent or guardian as a 
caregiver to the Department of Health, the Department of Health shall issue 
a Registered Identification Card to the designated caregiver of such 
individual at no cost. A Registered Identification Card issued under this 
subsection shall expire six (6) months after it is issued, and may only be 
renewed in the same manner that it is issued.24 
(f) A registry identification card, or its equivalent, that is issued 
under the laws of another state, district, territory, commonwealth, or insular 
possession of the United States that allows the medical use of marijuana by 
a visiting qualifying patient, or allows a person to assist with a visiting 
qualifying patient’s medical use of marijuana, shall have the same force and 
effect as a registry identification card issued by the department.25 
(g) Notwithstanding the other provisions of this Model Act, a valid 
registry identification card under the laws of another state shall not receive 
reciprocity in this state unless the health care professional that issued the 
certification or recommendation for the out-of-state registry identification 
card would be considered a Practitioner within this State.26 
II.  AREAS OF AGREEMENT AND DISAGREEMENT AMONG 
LEGALIZED STATES 
A. Variations Among Legalized States Regarding the Number and 
Type of Qualifying Medical Conditions 
One of the most fundamental aspects of any regulatory system for 
the distribution of medical cannabis is the list of medical conditions that 
allow patients to use cannabis legally. Often called “qualifying medical 
                                                 
 24. This section is intended to embody the additional safety protections for minor 
patients that this paper discusses. 
 25. This subsection is based on MICH. COMP. LAWS ANN. § 333.26424(k) (West 2016), 
part of Michigan’s regulatory scheme for medical cannabis. 
 26. This provision is intended to ensure that out-of-state identification cards will only 
receive reciprocity if the health care professional that issued the recommendation for it in the 
other state would have been considered a Practitioner within the meaning of the Model Act. 
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conditions,” “debilitating medical conditions,” or “qualifying health 
conditions,” this list, usually created by statute, ballot initiative, or 
regulation, determines which health conditions qualify any given patient for 
the use of medical cannabis in that state.27 While having a larger and more 
numerous list is not necessarily indicative of a superior distribution system, 
it does generally indicate that patients in states with broader lists will have a 
better chance at getting access to medical cannabis.28 Indeed, it seems 
axiomatic that any regulatory system for the distribution of medical cannabis 
should place the ability of patients to use cannabis to treat their health 
conditions as one of its highest priorities.29 
Every legalized state lists cancer and HIV/AIDS as a qualifying 
medical condition.30 Most legalized states also list cachexia (wasting 
syndrome), glaucoma, multiple sclerosis, and epilepsy and other seizure 
disorders as qualifying medical conditions.31 A handful of legalized states list 
post-traumatic stress disorder (PTSD) as a qualifying medical condition, and 
a few states list severe pain, nausea, or terminal illness as qualifying medical 
conditions.32 New Mexico law states that hospice patients are automatically 
considered to have a qualifying medical condition,33 and the District of 
Columbia catalogs “any condition for which treatment with medical 
marijuana would be beneficial, as determined by the patient’s physician” as 
a qualifying medical condition.34 
Illinois has perhaps the largest and most inclusive list of qualifying 
medical conditions, encompassing forty different diseases and disorders that 
allow patients to utilize medical cannabis to treat their health conditions.35 
Lupus, Lou-Gehrig’s Disease (ALS), muscular dystrophy, and Parkinson’s 
disease are all included in Illinois’ list, as are spinal cord injuries and Tourette 
syndrome.36 Noticeably absent from Illinois’ list is a qualifying health 
condition for chronic or severe pain, a broader category that California, 
Arizona, and others have adopted.37 
Another interesting legalized state in terms of its qualifying medical 
conditions is California. The Compassionate Use Act of 1996—also known 
                                                 
 27. Andrew J. Boyd, Medical Marijuana and Personal Autonomy, 37 J. MARSHALL L. 
REV. 1253, 1258-69 (2004). 
 28. See id. 
 29. Patient Access to Medical Marijuana in Washington State, WASH. STATE DEP’T OF 
HEALTH, at 20 (2008). 
 30. 28 Legal Medical Marijuana States and DC, PROCON, http://medicalmarijuana
.procon.org/view.resource.php?resourceID=000881&print=true (last visited Jan. 27, 2017). 
 31. Id. 
 32. Id. 
 33. N.M. CODE R § 7.34.3.7 (LexisNexis 2015). 
 34. D.C. CODE § 7-1671.01(17) (2015). 
 35. 410 ILL. COMP. STAT. 130/10 (2016). 
 36. Id. 
 37. CAL. HEALTH & SAFETY CODE § 11362.7(h)(6) (West 2004); ARIZ. REV. STAT. 
§ 36-2801(3)(b) (LexisNexis 2010); N.H. REV. STAT. ANN. §126-X:1(IX)(a)(2) (2016); OR. 
REV. STAT. § 475B.410(6)(b)(B) (2016). 
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as Proposition 215, a successful ballot initiative—allows Californians to use 
medical cannabis upon the recommendation of a physician for the treatment 
of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, 
migraine, or “any other illness for which marijuana provides relief.”38 The 
last item in the list, “[a]ny other chronic or persistent medical symptom that 
either: (A) substantially limits the ability of the person to conduct one or more 
major life activities as defined in the Americans with Disabilities Act of 
1990 . . . (B) [or] [i]f not alleviated, may cause serious harm to the patient’s 
safety or physical or mental health,” offers patients unique latitude for 
acquiring medical cannabis to treat a vast array of health conditions. 39 A 
plethora of various health conditions could theoretically constitute a 
qualifying medical condition under the California statute. 
The most restrictive legalized state’s list of qualifying medical 
conditions is probably that of New Hampshire’s, which allows patients to use 
medical cannabis for only chronic or terminal diseases, cachexia, severe pain, 
nausea, vomiting, seizures, and severe, persistent muscle spasms. While only 
seven conditions are listed as qualifying medical conditions under New 
Hampshire’s list, it is noteworthy that the list includes severe pain as a 
qualifying medical condition—a condition that is not on Illinois’ list.40 
B. The Ideal Regulatory System’s Rules Pertaining to the Number 
and Type of Qualifying Medical Conditions 
State regulatory systems with the greatest numbers of qualifying 
medical conditions give a more expansive number of patients the best 
opportunities to use medical cannabis to treat their medical conditions.41 
Thus, patients living under state distribution systems with more qualifying 
medical conditions have greater choice in treatment plans than those living 
under state distribution systems with a smaller number of qualifying medical 
conditions.42 While the advantages of greater patient choice remain unclear 
in certain respects, at least some patients are likely able to use medical 
cannabis instead of conventional pharmaceutical drugs, particularly 
opioids.43 This may mean that patients could use medical cannabis as an 
alternative to potentially more expensive pharmaceutical drugs that also 
carry unwanted side-effects, including higher risks of addiction.44 Indeed, in 
light of the recent media coverage of the opioid epidemic sweeping the 
                                                 
 38. CAL. HEALTH & SAFETY CODE § 11362.7(h)(12)(A)-(B) (West 2004). 
 39. Id. 
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United States, medical cannabis appears increasingly more attractive as a 
substitute treatment option for patients who would otherwise treat their health 
conditions using opioids. 
The best regulatory system for the distribution of medical cannabis 
should encompass a broad list of qualifying medical conditions to allow 
patients greater diversity in their treatment options. Allowing for more 
qualifying medical conditions for patient access to medical cannabis could 
save patients money in treating their health conditions or reduce traditional 
risks associated with prescription drugs.45 Particularly in the area of chronic 
pain, using medical cannabis as an alternative to prescription opioids could 
reduce the risk of drug addiction and lead to better treatment outcomes for 
patients.46 
Accordingly, Illinois’ list of qualifying medical conditions is 
probably the best list currently existing in the United States. An ideal 
regulatory system for distributing medical cannabis would adopt a list similar 
to Illinois’, with an eye toward expanding the list of qualifying medical 
conditions when any future medical research identifies new medical 
conditions that, with reasonable certainty, could be treated successfully with 
medical cannabis. Finally, the preferred list of qualifying medical conditions 
should include a provision like that found in California, giving privileged 
health care professionals broad discretion to recommend medical cannabis to 
patients for other health conditions not specifically enumerated in the list of 
qualifying health conditions, so long as the physician has reason to believe 
that medical cannabis could help treat the patient’s health condition within 
her sound medical judgment. Including such a provision in a state’s 
regulatory system for the distribution of medical cannabis could encourage 
health care professionals to engage in innovative treatment plans and 
participate in new research and development projects exploring the 
additional uses and safety risks of using medical cannabis.47 
C. Variations Among Legalized States Regarding Patient Access 
to Medical Cannabis Through Personal Cultivation and 
Dispensaries 
Another important aspect of any state’s regulatory system for the 
effective distribution of medical cannabis is a patient’s access to medical 
cannabis, either through personal cultivation or in-person purchases from 
approved dispensaries.48 Some states, such as New York, have restrictive 
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systems that do not allow for personal cultivation and only allow purchases 
at a limited number of dispensaries throughout the state.49 Other states, such 
as Colorado and Oregon, employ the opposite approach, allowing patients to 
cultivate a certain amount of their own medical cannabis or purchase medical 
cannabis at a large number of different dispensaries sprawled throughout 
each respective state.50 
Oregon currently has 521 dispensaries throughout the state where 
patients can obtain cannabis.51 In addition, Oregonian patients can cultivate 
up to twelve plants in residential zones and forty-eight plants in non-
residential zones, provided that they register as a grower for only themselves 
and meet certain criteria (a patient must be twenty-one years of age or older, 
not have been convicted of a Class A or Class B felony for the manufacture 
or delivery of a controlled substance in the previous two years or more than 
once, and pass a criminal background check).52 Individuals seeking to apply 
for licenses to create medical cannabis dispensaries in Oregon must pay a 
$4,000 application fee, get fingerprinted, and pass a criminal background 
check.53 Finally, a dispensary may not be located in a residential zone, within 
1,000 feet of a school, or within 1,000 feet of another medical marijuana 
dispensary.54 
Colorado currently has 525 dispensaries throughout the state,55 and 
patients or their caregivers can jointly cultivate up to six plants.56 Colorado 
permits three different kinds of medical cannabis dispensaries: (1) “Center 
Type I,” which may serve 1-300 patients and costs $9,000 to apply for and 
obtain state licensing; (2) “Center Type II,” which may serve 301-500 
patients and costs $16,000 to apply for and obtain state licensing; and (3) 
“Center Type III,” which may serve 501 or more patients and costs $22,000 
to apply for and obtain licensing.57 
In stark contrast to Oregon and Colorado, both of which contain 
hundreds of dispensaries throughout their respective states, New York 
currently has only twenty dispensaries throughout the entire state, and only 
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ten companies have been approved to operate those dispensaries.58 In fact, 
under New York’s current statutory regime, no more dispensaries can 
currently be created.59 In addition, New York imposes heavy application and 
registration fees for companies wishing to open a medical cannabis 
dispensary–companies must pay a non-refundable $10,000 application fee 
and a $200,000 registration fee (the registration fee is refunded if the 
company is denied registration).60 Finally, New York does not allow patients 
to personally cultivate medical cannabis.61 
In keeping with New York, Illinois has only forty-seven dispensaries 
located throughout the state, and patients may only purchase medical 
cannabis from one dispensary at a time.62 Patients must select the dispensary 
they wish to use and register it with the Illinois Department of Health; 
patients may change their dispensary later on, but patients have to fill out a 
form to change their dispensary and the change must also be registered with 
the Illinois Department of Health before it becomes effective.63 The Illinois 
Department of Health must approve individuals wanting to open a 
dispensary, and such individuals must pay a $5,000 application fee and a 
$30,000 registration fee.64 In addition, annual renewal fees for dispensaries 
total $25,000.65 The enabling statute, the Compassionate Use of Medical 
Cannabis Pilot Program Act, sunsets on July 1, 2020, and does not allow for 
more than a total of sixty dispensaries throughout the state.66 Finally, and 
perhaps most significantly, neither Illinois nor New York allows patients to 
personally cultivate medical cannabis.67 
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D. The Ideal Regulatory System’s Rules Pertaining to Patient 
Access to Medical Cannabis Through Personal Cultivation and 
Dispensaries 
An examination of Colorado, Oregon, New York, and Illinois 
illuminates the spectrum of efficiency of state regulatory attempts for the 
distribution of medical cannabis in terms of personal cultivation and 
dispensary facilities. Both Colorado and Oregon have hundreds of 
dispensaries throughout their respective states, and applying for and 
registering a new dispensary is relatively cheap. Additionally, both Colorado 
and Oregon allow for some kind of personal cultivation, with Oregon’s 
system being particularly generous for patients with a “green thumb.” 
Illinois, on the other hand, requires significant capital to start a dispensary 
and can only have sixty dispensaries by statute. New York is even more 
restrictive on both of these points, since it only allows one-third the number 
of dispensaries as Illinois, and requires even more capital to start a 
dispensary. Moreover, both Illinois and New York prohibit personal 
cultivation, which may restrict access to medical cannabis for poorer 
individuals.68 
The best regulatory system should adopt an approach similar to 
Colorado’s or Oregon’s pertaining to the issues of personal cultivation and 
dispensary registration, because allowing for more dispensaries is likely to 
reduce the geographical distances patients will need to travel to purchase 
medical cannabis, and encourage more efficient practices for delivery of 
medical cannabis to patients at individual dispensaries through market 
competition and banking services.69 In addition, allowing patients to cultivate 
their own medical cannabis could give poorer or extremely sick patients a 
cheaper and easier alternative for acquiring the necessary medical cannabis 
to treat their conditions.70 Nevertheless, even a free market approach to 
distribution should have enough regulation to ensure that only qualifying 
patients can purchase medical cannabis and that patients cannot acquire more 
medical cannabis than they are allowed to purchase at any given time. If these 
bare-bones regulations did not exist in a state’s regulatory system for the 
distribution of medical cannabis, that state may risk the DOJ enforcing 
federal marijuana prohibition in that state, as the 2013 DOJ memo on this 
topic suggests.71 
Several additional factors support the notion that the ideal regulatory 
system should reflect that of Colorado’s or Oregon’s. First, allowing personal 
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cultivation for patients is a crucial aspect of the most effective regulatory 
system for medical cannabis. Allowing personal cultivation would likely 
expand patient access to medical cannabis because it allows for poorer 
individuals or individuals unable to travel to dispensaries to grow their own 
cannabis instead of purchasing it.72 Personal cultivation also increases patient 
choice, since patients can elect to grow their own cannabis in customized 
amounts or types (so long as the individual does not exceed the statutory 
limits or requirements) and at times that are more convenient to them.73 Some 
patients may also have qualifying medical conditions that make it difficult 
for them to travel to dispensaries or caregiver arrangements that make it 
difficult for them to regularly get the medical cannabis they need from 
dispensaries to treat their health conditions. Personal cultivation could 
provide an alternative to patients in these situations, especially if they are an 
adult and are unable to secure a caregiver to assist them. 
Second, the most effective regulatory system for distributing medical 
cannabis should provide for an easy, cheap, and efficient process for 
individuals and companies to open new dispensaries. While the regulations 
should incorporate criminal background checks and certain licensing and 
zoning requirements on aspiring dispensary owners (as Colorado and Oregon 
do, for example) to protect the public,74 the application, registration, and 
renewal fees for dispensaries should not be unreasonable. It appears that the 
more capital a state requires for dispensaries to open and operate, the more 
likely it is that that state will have fewer dispensaries and less industry 
growth.75 Geographically large or populous states are likely to need a 
substantial number of dispensaries to provide adequate access to medical 
cannabis for patients.76 To the extent that patients have to travel long 
distances to reach a dispensary, or there are not enough dispensaries to meet 
patient needs in a geographic area, patient choice and access is undermined.77 
Additionally, if there are too few dispensaries throughout a state, a lack of 
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supply or competition may drive up the price of medical cannabis, thus 
further undermining patient access through prohibitive prices.78 
Third and finally, the best regulatory system should avoid statutory 
limits on the number of dispensaries that a state can have unless there is a 
compelling reason to do so. Allowing for dynamic growth in a state’s number 
of dispensaries is more likely to increase patient choice and access because 
of increased market competition, greater medical cannabis supply, and 
broader geographic coverage.79 While some state regulatory systems may 
wish to ensure that a particular geographic area does not become flooded with 
dispensaries, this mechanism could be accomplished by regulating 
dispensaries in a similar way as hospitals–states could require dispensaries 
to acquire a certificate of need for a particular geographic region before 
allowing them to open.80 This kind of approach—requiring a certificate of 
need for dispensaries to open rather than imposing a flat statutory maximum 
on the number of dispensaries allowed to operate in the state—is more 
particularized and still likely to accomplish the goal of preventing an 
undesirable flood of dispensaries in any one geographic region.81  
E. Variations Among Legalized States Regarding Privileged 
Health Care Professionals and Recommendations of Medical 
Cannabis to Patients 
Under the federal Controlled Substances Act, cannabis is a Schedule 
I substance–the same scheduling as heroin, ecstasy, and LSD.82 A Schedule 
I substance is a substance that (1) “has a high potential for abuse,” (2) “has 
no currently accepted medical use in treatment in the United States,” and (3) 
“[has] a lack of accepted safety for use of the drug or other substance under 
medical supervision.”83 Thus, in legalized states, health care professionals do 
not directly prescribe cannabis to patients. Instead, legalized states generally 
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require recommendations or certifications of medical cannabis to patients 
with a qualifying medical condition from health care professionals with 
recommendation privileges.84 
Physicians have a First Amendment right to recommend medical 
cannabis to patients within honest medical judgment made in good faith.85 In 
Conant v. Walters, California physicians had recommended medical 
cannabis to patients under the Compassionate Use Act of 1996. The DEA 
had stated that it would seek enforcement actions against the recommending 
physicians–specifically, the DEA threatened revocation of the physicians’ 
registration to write prescriptions for controlled substances.86 The physicians 
and their patients receiving the recommendations mounted a class action First 
Amendment challenge to the DEA’s response to the Compassionate Use 
Act.87 The United States District Court for the Northern District of California 
held in favor of the physicians and patients, reasoning that the doctrine of 
constitutional doubt protected a physician’s right to recommend medical 
cannabis to qualifying patients based on his honest medical judgment made 
in good faith.88 The United States Court of Appeals for the Ninth Circuit 
affirmed, further emphasizing that the government could not prohibit a 
physician from speaking about the medical benefits of marijuana with his 
patient because the prohibition targeted the physician’s speech on content 
and viewpoint grounds.89 
Legalized states differ in their regulations concerning health care 
professionals recommending medical cannabis to patients, but their 
differences concerning this issue are less pronounced than in other legal 
issues related to regulating medical cannabis. State differences in this area 
mainly focus on what types of health care professionals are allowed to 
recommend medical cannabis to patients and whether health care 
professionals must register with the state in order to obtain recommendation 
privileges.90 The existence of a physician-patient relationship is generally 
required for a physician to recommend medical cannabis to a patient.91 
In New York, for example, any physician licensed in the state and in 
good standing may recommend medical cannabis to patients, so long as they 
also comply with the course and registration requirements.92 Specifically, 
New York physicians must pay $250 and complete a 4-hour course before 
registering with the New York Department of Health to qualify for medical 
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cannabis recommendation privileges.93 As of June 6, 2017, only 1,043 
physicians in New York have medical cannabis recommendation 
privileges.94 Because of the small number of physicians that have fulfilled 
the statutory requirements to receive recommendation privileges and the lack 
of a published list of physicians with recommendation privileges whom do 
not wish to be published on the list, many patients in New York have 
complained of difficulty in finding a physician that can recommend medical 
cannabis to them.95 Indeed, this may explain why barely 21,000 patients in 
New York have currently taken advantage of medical cannabis to treat their 
debilitating health conditions.96 Nevertheless, some private organizations are 
taking steps to list privileged New York physicians on the Internet, and this 
may prove useful to some New York patients.97 
In Arizona, any doctor of medicine (MD), doctor of osteopathy 
(DO), naturopathic physician (ND), or homeopathic physician (MD(H) or 
DO(H)) who is licensed in the state and in good standing may recommend 
medical cannabis to patients.98 A physician’s recommendation takes the form 
of a written certification by the physician to the patient in the course of the 
physician-patient relationship, and certifies that “in the physician’s 
professional opinion the patient is likely to receive therapeutic or palliative 
benefit from the medical use of marijuana to treat or alleviate the patient’s 
debilitating medical condition or symptoms associated with the debilitating 
medical condition.”99 
Some states broaden the scope of individuals who can recommend 
medical cannabis to patients with qualifying health conditions. New Mexico, 
for example, allows any “person licensed in New Mexico to prescribe and 
administer drugs that are subject to the Controlled Substances Act” to 
recommend medical cannabis to qualifying patients.100 Thus, MDs, DOs, and 
nurse practitioners and physician’s assistants may recommend medical 
cannabis in New Mexico. Washington also broadens the scope of individuals 
with recommendation privileges in a similar fashion.101 
In addition, Rhode Island and Vermont allow certain licensed 
healthcare professionals from other states to recommend medical cannabis to 
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qualifying patients within their respective states. Rhode Island allows any 
licensed physician in good standing from Rhode Island, Massachusetts, or 
Connecticut to recommend medical cannabis to qualifying patients.102 Rhode 
Island also extends recommendation privileges to physician assistants and 
registered nurse practitioners from within Rhode Island, a similar extension 
to those seen in New Mexico and Washington.103 Vermont gives 
recommendation privileges to any licensed MD, DO, ND, physician’s 
assistant, or advanced practice registered nurse in good standing from 
Vermont, New Hampshire, Massachusetts, or New York, thereby 
incorporating a broader scope of individuals with recommendation privileges 
from within and outside the state.104 
F. The Ideal Regulatory System’s Rules Pertaining to Privileged 
Health Care Professionals and Recommendations of Medical 
Cannabis to Patients 
The best regulatory system for distributing medical cannabis should 
emulate Vermont’s or Rhode Island’s regulatory system while taking care to 
avoid the burdensome regulations found in New York’s regulatory system. 
Indeed, New York’s onerous regulations that require physicians to pay a fee 
and take a course to gain recommendation privileges may be one reason why 
there appears to be a shortage of physicians in New York with 
recommendation privileges.105 Additionally, New York’s statutory refusal to 
publish a list of non-consenting physicians with recommendation privileges 
gives rise to additional barriers to patient access and choice, since patients 
simply cannot find a physician who can recommend medical cannabis to 
them legally.106 The optimal design of a regulatory system for distributing 
medical cannabis should be to protect the interests of patients and the safety 
of the public without placing undue burdens on patients to get the treatment 
they need for their health conditions.107 In sum, New York’s regulatory 
system places substantial obstacles in the path of patients with qualifying 
health conditions through its refusal to extend recommendation privileges to 
other health care professionals besides physicians, its barriers to physicians 
from acquiring recommendation privileges, its prohibition of out-of-state 
physicians with recommendation privileges from recommending medical 
cannabis in New York, and its lack of a complete published list of physicians 
with recommendation privileges. Thus, restrictions of this kind ought to be 
avoided to achieve the optimal regulatory system for distributing medical 
cannabis to qualifying patients–that is, a system that makes it as simple as 
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possible for any health care professionals adequately trained and licensed to 
obtain recommendation privileges in a way that is also visible to the public. 
Additionally, the best regulatory system should incorporate an 
extension of recommendation privileges to health care professionals beyond 
physicians. Many of the qualifying medical conditions in the legalized states 
are reasonably within the ability of health care professionals other than 
physicians to diagnose.108 Chronic pain or nausea, for example, probably 
does not require a licensed physician to diagnose.109 Thus, allowing physician 
assistants or registered nurse practitioners to have recommendation 
privileges for at least some qualifying medical conditions is likely to improve 
efficiency in the medical cannabis corner of the health care industry, allowing 
a greater number of qualifying patients to get medical cannabis in a faster 
and easier way. Indeed, if a state did not want to allow non-physician health 
care professionals to recommend medical cannabis for more complicated 
diseases (e.g., cancer), then it could create exceptions in its regulatory 
scheme for specific qualified health conditions that it deems more important 
to have physicians diagnose. Any remaining qualifying health conditions that 
are more easily diagnosed could trigger a statutory allowance for other health 
care professionals to recommend medical cannabis as to those qualified 
health conditions. 
Moreover, the best regulatory system should provide for a public 
disclosure of health care professionals with recommendation privileges to 
give qualifying patients a better idea of which health care professionals they 
can go to in order to receive a recommendation for medical cannabis. Many 
qualifying patients have serious medical conditions, such as cancer or 
terminal illness, and a public list of all health care professionals with 
recommendation privileges could help improve the efficacy of the 
distribution system because more patients will know which health care 
professionals they can visit to get the recommendation they need to register 
for a medical cannabis ID card, and patients will have more choices in 
deciding which health care professional they wish to see.110 The alternative 
to such a system would likely be riddled with problems similar to those which 
New York is currently facing from its lack of a published list.111 Thus, patient 
convenience and access could be greatly enhanced by such a public 
disclosure. 
Finally, the best regulatory system should incorporate reciprocity 
provisions that allow health care professionals with recommendation 
privileges in other states to recommend medical cannabis in the regulating 
state, provided that the regulating state’s relevant provisions pertaining to 
qualifying health care professionals are sufficiently similar to the provisions 
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of the states receiving reciprocity. While this may not have a large impact on 
increasing the number of health care professionals with recommendation 
privileges accessible to qualifying patients in state groupings that are large in 
geographic area (e.g., Montana or Idaho), it has the potential to increase 
patient access to health care professionals with recommendation privileges 
in tighter state groupings (e.g., Maryland and Delaware or New York and 
New Jersey), since privileged health care professionals in tighter state 
groupings may be more likely to travel, live, or work in a cluster of states 
where there may be shortages of particular types of health care services.112 
G. Variations Among the Legalized States Regarding Patient 
Registration Requirements and State Reciprocity 
All legalized states require some form of patient registration or 
identification (ID) cards.113 Generally, once a qualifying patient has received 
a recommendation from a privileged health care professional, the patient can 
register with the state’s Department of Health in order to receive an ID card 
which allows the patient to purchase medical cannabis at authorized places 
of distribution.114 Registration usually requires the presentment of the 
patient’s medical records (including the privileged physician’s 
recommendation), a valid in-state photo ID (e.g., a driver’s license), and 
proof of in-state residency.115 Registration lists or databases are usually 
maintained by the state’s Department of Health and contain confidentiality 
protections.116 If a patient wishes to renew their ID card upon expiration, or 
if it is lost or stolen, she must generally acquire another recommendation 
from a privileged health care professional and pay a renewal fee.117 One 
major issue among legalized states is whether any given legalized state’s 
regulatory system recognizes ID cards from other states and, if so, what the 
legal significance of that recognition is. Another issue is the amount of 
money a patient must pay to get an ID card and to annually renew the ID 
                                                 
 112. Recent Studies and Reports on Physician Shortages in the US, ASS’N OF AM. MED. 
COLLEGES, (2012), https://www.aamc.org/download/100598/data. 
 113. In Washington, however, patients with qualifying health conditions may purchase 
medical cannabis without a “recognition card,” so long as they comply with the purchasing, 
possession, and cultivation standards set out in the statute for individuals who do not register 
in Washington’s database. WASH. REV. CODE. ANN. § 69.51A.210(3) (West 2016). 
 114. See MICH. COMP. LAWS ANN. § 333.26426(a) (West 2016). 
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residency. Id. 
 116. See WASH. REV. CODE ANN. § 69.51A.230 (West 2015). 
 117. Provided that the patient’s card has been lost or stolen, Washington allows a 
patient to get a new “recognition card” without getting another recommendation from a 
privileged health care professional; however, if the patient does not get another 
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card. Finally, states may have additional requirements for minor patients and 
their caregivers, including a higher registration fee.118 
New York requires patients to pay a $50 registration fee in order to 
get an ID card for medical cannabis, although the New York Department of 
Health may waive the fee in cases of financial hardship.119 Additionally, New 
York does not recognize ID cards from outside the state.120 Cardholding 
patients in New York must pay $50 annually to renew their ID cards.121 
Furthermore, a cardholding patient must receive another recommendation 
from a privileged health care professional before he or she can renew their 
ID card.122 New York does not allow for personal cultivation, so cardholding 
patients may only purchase medical cannabis from dispensaries within the 
state.123 Finally, recommended patients must be eighteen years of age or 
assign a caregiver that is at least twenty-one years of age in order to acquire 
an ID card.124 
Oregon has a higher registration fee than New York, requiring 
recommended patients to pay $200 in order to get an ID card for the purchase 
of medical cannabis from dispensaries.125 Persons participating in the 
Supplemental Nutrition Assistance Program (“SNAP”) are only required to 
pay $60 to get an ID card, and persons receiving SSI benefits or who are 
veterans are only required to pay $20 to get an ID card.126 An ID card in 
Oregon allows for both purchase and personal cultivation.127 To get an ID 
card, a qualifying patient must present proof of residency in Oregon, medical 
records (including the privileged physician’s recommendation), and be 
eighteen years of age, unless the patient designates at least one caregiver who 
is a parent or legal guardian.128 ID cards must be renewed annually with an 
additional privileged physician’s recommendation, and the fee for renewal is 
$200.129 Oregon does not recognize ID cards from other states.130 
Michigan has a $60 registration fee for both applications and 
renewals of ID cards. A patient must be at least eighteen years of age, unless 
the patient designates his parent or legal guardian as his primary caregiver 
                                                 
 118. See ARIZ. ADMIN. CODE § R9-17-102 (2017). 
 119. N.Y. PUB. HEALTH LAW § 3363(2)(f). 
 120. N.Y. Dep’t of Health, Information for Patients, HEALTH.NY.GOV, 
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 124. N.Y. PUB. HEALTH LAW § 3363(3). 
 125. Oregon Health Authority, OMMP Cardholder Fees, OREGON.GOV, http://www.
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 127. OR. ADMIN. R. 333-008-0020. 
 128. OR. REV. STAT. § 475B.415. 
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and the primary caregiver gets certifications from at least two privileged 
physicians.131 The patient must also show proof of in-state residency for 
every application or renewal.132 Another written certification from a 
privileged physician is required every time a patient wants to renew his or 
her ID card.133 A patient’s ID card must be renewed every two years.134 
Michigan does not offer discounts on application or renewal fees for poor 
patients. Michigan allows for registered patients without caregivers to 
personally cultivate up to twelve plants at a time.135 An interesting aspect of 
Michigan’s regulatory system is that it recognizes ID cards from outside the 
state, so long as that ID card is valid under the state laws of the state that 
issued it. Valid out-of-state ID cards are legally recognized as if they had 
been issued by the state of Michigan, and carry the same force and effect as 
Michigan ID cards.136 
Arizona has a $150 registration and renewal fee for its ID cards.137 
Arizona requires registered patients to renew their ID cards annually.138 A 
qualified patient must be at least eighteen years of age to obtain an ID card, 
unless the patient designates his parent or legal guardian as his primary 
caregiver and the patient receives two certifications from privileged 
physicians.139 If the patient is under the age of eighteen and must designate 
his parent or guardian as his primary caregiver, he must pay an increased 
registration fee of $350 (renewal fees are also $350 in this case).140 For all 
applications and renewals, the patient must present a new certification from 
a privileged health care professional (or two certifications, if the patient is 
under the age of eighteen).141   
Additionally, all patients must present proof of in-state residency and 
photo identification for registration or renewal.142 Qualifying patients of at 
least eighteen years of age that are in the SNAP program only have to pay 
$75 for registration or renewal fees, and qualifying patients under the age of 
eighteen that are in the SNAP program only have to pay $275 for registration 
or renewal fees.143 Patients over the age of eighteen and the primary 
caregivers of patients under the age of eighteen may cultivate up to twelve 
plants if they indicate on their application or renewal form that there is not a 
dispensary within twenty-five miles of the patient’s home, provided the 
                                                 
 131. MICH. COMP. LAWS ANN. 333.26426(b) (West 2016). 
 132. Id. § 333.26426(a)(6). 
 133. Id. § 333.26426(a)(1). 
 134. Id. § 333.26426(e). 
 135. Id. § 333.26424(a). 
 136. Id. § 333.26424(k). 
 137. ARIZ. ADMIN. CODE § R9-17-102 (2012). 
 138. Id. § R9-17-108(A). 
 139. ARIZ. REV. STAT. §§ 36-2804.02-.03 (2014). 
 140. ARIZ. ADMIN. CODE § R9-17-102. 
 141. ARIZ. REV. STAT. §§ 36-2804.02-.03. 
 142. Id. § 36-2804.02(A)(3)(a). 
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Department of Health verifies that the information provided on the 
application or renewal form is accurate.144 Finally, Arizona recognizes out-
of-state ID cards, provided that they are valid under the laws of the state in 
which they were issued; however, valid out-of-state ID cards may not be used 
to purchase medical cannabis at any Arizona dispensary (thus only protecting 
card-carrying out-of-state patients from criminal penalties for possession of 
medical cannabis).145 
H. The Ideal Regulatory System’s Rules Pertaining to Patient 
Registration Requirements and State Reciprocity 
As to the issues pertaining to registration, renewal, and reciprocity 
of ID cards, the best regulatory system for distributing medical cannabis 
should incorporate various elements found in New York, Oregon, Michigan, 
and Oregon. First, the regulatory system should keep registration and renewal 
fees as low as is practicable. New York’s low registration and renewal fee of 
$50 is a good starting point, but the best regulatory system should seek to 
lower the fee even more, since lowering the fee would increase patient access 
to medical cannabis. Another positive aspect of New York’s regulatory 
system that should be emulated in an ideal regulatory system is the ability of 
the state to completely waive the fee for indigent patients. Rather than simply 
lowering the cost of the fee for specific individuals (SNAP participants, 
veterans, etc.), the ideal regulatory system should also provide for a complete 
waiver of the fee for low-income patients. A showing of low-income should 
not be overly difficult to prove; a showing of Medicaid eligibility or SNAP 
eligibility should be sufficient.146 If the state cannot afford to completely 
waive the fee for such individuals, it should make the fee as minimal as 
possible to the extent that it is financially practicable. Indeed, to the extent 
that patients cannot afford the fees necessary to obtain or renew the necessary 
ID cards, the fundamental goal of allowing patients access to medical 
cannabis to treat their health conditions is undermined, since patients will be 
unable to purchase medical cannabis without an ID card. Additionally, the 
best regulatory system should avoid charging higher registration or renewal 
fees for minors (as Arizona does), because the caregivers of minor patients 
(parents or legal guardians) are already managing the debilitating medical 
conditions of their children.147 Imposing an extra cost on parents who are 
already shouldering the burdens of treating their child’s medical conditions 
is an unnecessarily depraved act, absent a compelling state financial need to 
do so. 
                                                 
 144. ARIZ. REV. STAT. § 36-2804.02(A)(3)(f). 
 145. Id. § 36-2804.03(C). 
 146. For example, Arizona lowers its registration fees if a qualifying patient participates 
in SNAP. ARIZ. ADMIN. CODE § R9-17-102. 
 147. Id.  
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Second, the ideal regulatory system should allow for the automatic 
right of personal cultivation of medical cannabis immediately upon the 
issuance of an ID card, provided that the patient is at least eighteen years old. 
If the patient is not eighteen years old and the ID card is instead procured 
upon the designation of a caregiver, the caregiver should have the right to 
personally cultivate medical cannabis on behalf of the minor-patient. 
Geographic distance from dispensaries can provide a barrier to patient access 
to medical cannabis in the absence of the ability to personally cultivate.148 
Thus, allowing for personal cultivation upon the issuance of an ID card can 
help alleviate the challenges geographically isolated patients face.149 
Further, allowing for personal cultivation increases patient choice 
and even patient access to medical cannabis, since personal cultivation 
allows for patients to conveniently retrieve medical cannabis within their 
own home without spending time and money on travel to reach the nearest 
dispensary. Some patients may even have debilitating medical conditions that 
make it difficult for them to travel to dispensaries, and caregivers may not 
always be available to procure the medical cannabis for patients to which 
they are assigned; personal cultivation can alleviate these problems as well. 
Lastly, the reasonably standardized system of ID cards adopted in legalized 
states can sufficiently ensure that minor patients are not personally 
cultivating medical cannabis through the restriction that only a minor 
patient’s caregiver may cultivate medical cannabis. Thus, an automatic right 
to personally cultivate medical cannabis upon the issuance of an ID card 
would not pose a substantial enough risk of minors illegally cultivating 
medical cannabis to outweigh the benefits of allowing automatic personal 
cultivation. This strongly supports the notion of adopting a more unified body 
of law, such as the Model Act in this Note, as doing so would help protect 
minor children and the broader public. 
Third, the best regulatory system should, at least in some cases, 
require renewal of ID cards less frequently than annually. Michigan’s 
regulatory system (requiring renewal every two years) takes a better 
approach than Oregon’s, Arizona’s, or New York’s (all of which require 
annual renewal), but it is still too standardized to be ideal. For example, 
patients with qualifying medical conditions such as epilepsy or AIDS should 
not be required to renew their ID cards every year, for several reasons. First, 
qualifying medical conditions such as epilepsy or AIDS are currently 
incurable. Patients with incurable conditions are using medical cannabis to 
manage their health conditions on a permanent basis.150 While the renewal 
process usually requires a new certification from a privileged physician on 
an annual basis–presumably to check in on the patient’s continuing need for 
medical cannabis–requiring annual renewal for patients with incurable 
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qualifying medical conditions does nothing but impose additional costs on 
those patients. In addition to a patient with an incurable qualifying medical 
condition having to pay for the renewal fee each year, the patient must also 
pay for an additional doctor’s visit to a privileged health care professional to 
receive a new certification for the renewal. Thus, the standardized 
requirement that all qualifying patients (including patients with incurable 
qualifying health conditions) renew their ID cards each year imposes undue 
financial burdens and at least some unnecessary costs on unfortunate patients 
with incurable qualifying health conditions. 
In addition, cardholding patients with incurable conditions could 
simply meet with a privileged physician as they need to–changes in their 
medical condition or symptoms or desires for changes in their treatment plan 
could prompt additional visits to physicians rather than a universal 
requirement that they meet with a privileged physician once every year when 
it may be unnecessary to do so. As a result, an ideal regulatory system should 
impose more frequent renewal requirements only for those patients that have 
qualifying medical conditions that are not incurable or unlikely to remain 
constant. Third, cardholding patients with qualifying medical conditions that 
are not incurable may still economically benefit from a longer issuing period 
for their IDs because they would not have to pay as many renewal fees. In 
sum, the best regulatory system for the distribution of medical cannabis to 
patients should tailor its ID card issuing period to its list of qualifying medical 
conditions instead of imposing a universal requirement. If a universal 
requirement is unavoidable, the issuing period for ID cards should still be 
longer than one year. 
Another pillar of the best regulatory system for the distribution of 
medical cannabis should constitute mandatory caregiver delegations for 
qualifying patients who are minors. Furthermore, the ideal regulatory system 
should include the requirement that caregivers for qualifying minor-patients 
be the minor’s parent or legal guardian. All legalized states currently require 
some person at least eighteen years of age to preside over the purchase, 
cultivation, and treatment aspects of qualifying patients that are not yet 
adults. Legalized states also generally require that the caregiver be either a 
parent or guardian of the qualifying minor-patient. New York’s regulatory 
system requires that a minor’s caregiver be at least twenty-one years old, but 
this may not completely optimal. Most parents or legal guardians of 
qualifying minor-patients will be twenty-one years old, but there may be 
some situations where that is not the case. 
Specifically, very young children sometimes use medical cannabis 
for the treatment of severe epilepsy (usually after exhausting conventional 
prescription drugs).151 There may be some situations in which a very young 
child could have severe epilepsy as a qualifying medical condition and the 
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child’s only parent is not yet twenty-one years of age. Assuming, arguendo, 
that the child also has no extended family (such as grandparents) that could 
assume the role of caregiver under the relevant state statute, the child would 
be denied access to what could be his best or last hope in treating a severe 
seizure disorder. In these narrow situations, the best regulatory system ought 
to include either an exception to the requirement that the caregiver parent or 
guardian be twenty-one years of age, or simply make the age requirement for 
caregiver parents or guardians eighteen instead of twenty-one. 
Setting aside the age requirement for caregivers, a state has an 
especially strong interest in protecting the health and safety of children, and 
medical cannabis should never be used to treat children without the approval 
of both a privileged physician and the minor-patient’s parent or legal 
guardian. Requiring the consent of parents or guardians in such situations, 
and requiring the consenting parent or guardian to assume the duty of 
becoming the child’s caregiver, ensures that children do not get access to 
medical cannabis in situations the law does not allow. By requiring parents 
or guardians to become caretakers for the minor-patient, minors are removed 
from any cultivation and purchasing activities related to medical cannabis. 
Thus, the state fulfills its interest in protecting children and reduces the risk 
of illegal drug possession or trafficking resulting from allowing children to 
use medical cannabis to treat their debilitating health conditions. While 
mandatory caregiver provisions for qualifying minor-patients are an essential 
element of the ideal regulatory scheme for distributing medical cannabis, a 
regulating state should also take care to not impose extra fees on registration 
and renewal of ID cards for qualifying patients who are minors. 
Finally, the preeminent regulatory system for the distribution of 
medical cannabis should include mandatory dual-certification from 
privileged health care professionals for qualifying patients who are minors. 
This dual-certification requirement should apply to both a qualifying minor-
patient’s initial registration and to every renewal of the minor-patient’s ID 
card. Because of the heightened state interest in protecting children, requiring 
at least two privileged health care professionals to provide recommendations 
before issuing the minor-patient an ID card under the supervision of a 
caregiver parent or guardian is appropriate. The ideal regulatory system may 
also want to include a requirement that the privileged health care 
professionals issuing recommendations for children have a higher degree of 
specialty (i.e. only allow licensed physicians recommendation privileges for 
children rather than nurse practitioners or physician assistants). 
CONCLUSION 
The legalization of medical cannabis throughout the United States 
has presented several key legal issues, and is likely to introduce more issues 
as some states legalize cannabis for recreational use. From the ability of 
health care professionals to recommend medical cannabis to the way a state 
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creates and manages dispensaries for patients with qualifying medical 
conditions, several states have already tried a multitude of approaches. 
Thousands of patients around the nation now use medical cannabis to treat 
dozens of health conditions, and some parents and physicians are boldly 
using medical cannabis to try to treat sick children in innovative ways that 
produce fewer negative results than conventional treatments.152 
As more states legalize medical cannabis, the regulatory styles and 
schemes concerning these issues will invariably mutate and shift in new and 
interesting directions. Nevertheless, it remains clear that the best regulatory 
system is a blend of the existing state experiments. The best regulatory 
system for the distribution of medical cannabis must focus on expanding 
patient access and choice while protecting the dignity and individual liberty 
of patients so they can live the best lives in light of their unfortunate physical 
circumstances. The first way this is best accomplished is by having an 
expansive list of qualifying medical conditions with the potential for growth 
so any medical condition which a physician believes medical cannabis could 
help alleviate can be legally treated with medical cannabis. Second, an 
effective regulatory system for distributing medical cannabis must allow for 
generous personal cultivation and easily- and cheaply-established 
dispensaries so market competition improves the effective delivery of 
medical cannabis to patients while reducing its price and lessening a patient’s 
burden on acquiring it.153 Third, the ideal regulatory system must allow 
recommendation privileges to a broad swath of health care professionals that 
are easily identified and accessed by qualifying patients to ensure that 
patients know who they can go to in order to discuss the possibility of using 
medical cannabis as a treatment in a timely manner. Finally, the best 
regulatory system must break down the barriers of patient registration by 
reducing the cost of application and renewal and providing for generous 
reciprocity between and among the various state registration systems. 
If these processes are implemented correctly, states can effectively 
protect the public in the face of legalized medical cannabis while ensuring 
that those who are most sick in our society have easy, effective, fast, cheap, 
and safe access to an incredible treatment that our society is just beginning 
to understand. The evolving decency of our society demands an end to the 
unwarranted attacks on the dignity of dying patients who use medical 
cannabis as nothing more than an effort to experience a brief reprieve from 
their quiet desperation and physical torment. If an individual can derive 
medical benefit from the use of cannabis, our constitutional system of 
ordered liberty affords that individual the right to use it. 
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